Bariatric Surgery for Treatment of Morbid Obesity in Adults

Overview

Journal Korean J Intern Med

Date 2025 Jan 8

PMID 39778524

Authors

Ki Bum Park

Kyong-Hwa Jun

Affiliations

Soon will be listed here.

Abstract

Morbid obesity requires active intervention, with treatment options including lifestyle modification, pharmacotherapy, and surgery. As the prevalence of obesity continues to rise in Korea, it is crucial for specialists and general practitioners to have a comprehensive understanding of obesity and its management. Bariatric surgery is the most effective treatment modality for obesity, leading to significant weight loss and metabolic benefits. It involves surgical alterations of normal anatomical structures to improve overall health. Therefore, selecting the appropriate procedure based on the individual characteristics of patients is crucial. This review highlights the two most commonly performed bariatric procedures worldwide, including in Korea: sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB). Furthermore, it provides a comprehensive overview of the surgical techniques involved in SG and RYGB, addresses potential complications, and presents findings from key studies on the weight loss and metabolic outcomes of these surgeries. Additionally, to support clinical application, the review provides outcome data for these procedures based on studies conducted in Korean populations. In addition to SG and RYGB, this review briefly introduces other surgical and endoscopic options, as well as pharmacological treatments that are currently available or may become viable options in the near future.

References

Kauppila J, Tao W, Santoni G, von Euler-Chelpin M, Lynge E, Tryggvadottir L . Effects of Obesity Surgery on Overall and Disease-Specific Mortality in a 5-Country Population-Based Study. Gastroenterology. 2019; 157(1):119-127.e1. DOI: 10.1053/j.gastro.2019.03.048. View

Colquitt J, Pickett K, Loveman E, Frampton G . Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014; (8):CD003641. PMC: 9028049. DOI: 10.1002/14651858.CD003641.pub4. View

Lee W, Hur K, Lakadawala M, Kasama K, Wong S, Chen S . Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis. 2012; 9(3):379-84. DOI: 10.1016/j.soard.2012.07.015. View

Samarasinghe S, Leca B, Alabdulkader S, Dimitriadis G, Davasgaium A, Thadani P . Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial. Lancet. 2024; 403(10443):2489-2503. DOI: 10.1016/S0140-6736(24)00538-5. View

Seeley R, Chambers A, Sandoval D . The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes. Cell Metab. 2015; 21(3):369-78. PMC: 4351155. DOI: 10.1016/j.cmet.2015.01.001. View

Kim J, Kim M, Park J, Lee S, Kim J, Cho Y . Outcomes and Adverse Events After Bariatric Surgery: An Updated Systematic Review and Meta-analysis, 2013-2023. J Metab Bariatr Surg. 2024; 12(2):76-88. PMC: 10771970. DOI: 10.17476/jmbs.2023.12.2.76. View

Wilding J, Batterham R, Calanna S, Davies M, Van Gaal L, Lingvay I . Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021; 384(11):989-1002. DOI: 10.1056/NEJMoa2032183. View

Bower G, Toma T, Harling L, Jiao L, Efthimiou E, Darzi A . Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology. Obes Surg. 2015; 25(12):2280-9. DOI: 10.1007/s11695-015-1691-x. View

Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View

10.

Bae E, Lee Y, Yun C, Heo Y . Effects of surgical weight loss for treating obstructive sleep apnea. Sleep Breath. 2014; 18(4):901-5. DOI: 10.1007/s11325-014-0956-2. View

11.

van de Laar A, Emous M, Hazebroek E, Boerma E, Faneyte I, Nienhuijs S . Reporting Weight Loss 2021: Position Statement of the Dutch Society for Metabolic and Bariatric Surgery (DSMBS). Obes Surg. 2021; 31(10):4607-4611. DOI: 10.1007/s11695-021-05580-x. View

12.

Peterli R, Wolnerhanssen B, Peters T, Vetter D, Kroll D, Borbely Y . Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial. JAMA. 2018; 319(3):255-265. PMC: 5833546. DOI: 10.1001/jama.2017.20897. View

13.

Currie A, Kaur V, Carey I, Al-Rubaye H, Mahawar K, Madhok B . Obstructive sleep apnea remission following bariatric surgery: a national registry cohort study. Surg Obes Relat Dis. 2021; 17(9):1576-1582. DOI: 10.1016/j.soard.2021.05.021. View

14.

Alvarenga E, Lo Menzo E, Szomstein S, Rosenthal R . Safety and efficacy of 1020 consecutive laparoscopic sleeve gastrectomies performed as a primary treatment modality for morbid obesity. A single-center experience from the metabolic and bariatric surgical accreditation quality and improvement program. Surg Endosc. 2015; 30(7):2673-8. DOI: 10.1007/s00464-015-4548-4. View

15.

Caiazzo R, Lassailly G, Leteurtre E, Baud G, Verkindt H, Raverdy V . Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study. Ann Surg. 2014; 260(5):893-8. DOI: 10.1097/SLA.0000000000000945. View

16.

Hu Z, Sun J, Li R, Wang Z, Ding H, Zhu T . A Comprehensive Comparison of LRYGB and LSG in Obese Patients Including the Effects on QoL, Comorbidities, Weight Loss, and Complications: a Systematic Review and Meta-Analysis. Obes Surg. 2019; 30(3):819-827. PMC: 7347514. DOI: 10.1007/s11695-019-04306-4. View

17.

Salminen P, Gronroos S, Helmio M, Hurme S, Juuti A, Juusela R . Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss, Comorbidities, and Reflux at 10 Years in Adult Patients With Obesity: The SLEEVEPASS Randomized Clinical Trial. JAMA Surg. 2022; 157(8):656-666. PMC: 9218929. DOI: 10.1001/jamasurg.2022.2229. View

18.

Eisenberg D, Shikora S, Aarts E, Aminian A, Angrisani L, Cohen R . 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis. 2022; 18(12):1345-1356. DOI: 10.1016/j.soard.2022.08.013. View

19.

Iwakiri K, Fujiwara Y, Manabe N, Ihara E, Kuribayashi S, Akiyama J . Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021. J Gastroenterol. 2022; 57(4):267-285. PMC: 8938399. DOI: 10.1007/s00535-022-01861-z. View

20.

Kim K, Haam J, Kim B, Kim E, Park J, Rhee S . Evaluation and Treatment of Obesity and Its Comorbidities: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity. J Obes Metab Syndr. 2023; 32(1):1-24. PMC: 10088549. DOI: 10.7570/jomes23016. View